Polymorphism in Xeroderma Pigmentosum Complementation Group C Codon 939 and Aflatoxin B1–Related Hepatocellular Carcinoma in the Guangxi Population

Hepatology

Volumn 52, Issue 4, 2010, Pages 1301-1309

  Long, Xi Dai ^a,b   Ma, Yun ^c   Zhou, Yuan Feng ^b   Ma, Ai Min ^b   Fu, Guo Hui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; DNA BINDING PROTEIN; XPC PROTEIN, HUMAN;

ARTICLE; ASIAN; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CHINA; CODON; GENETIC POLYMORPHISM; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MORTALITY;

AFLATOXIN B1; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHINA; CODON; DNA-BINDING PROTEINS; HUMANS; LIVER NEOPLASMS; POLYMORPHISM, GENETIC;

MLCS; MLOWN;

EID: 77957946649     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23807     Document Type: Article

References (35)

1. Wang JS, Huang T, Su J, Liang F, Wei Z, Liang Y, et al. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People’s Republic of China. Cancer Epidemiol Biomarkers Prev 2001; 10:143-146.
2. Wang JS, Groopman JD. DNA damage by mycotoxins. Mutat Res 1999;424:167-181.
3. Wood RD. DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie 1999;81:39-44.
4. Wilson DM III, Thompson LH. Life without DNA repair. Proc Natl Acad Sci U S A 1997;94:12754-12757.
5. Long XD, Ma Y, Qu DY, Liu YG, Huang ZQ, Huang YZ, et al. The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China. Ann Epidemiol 2008;18: 572-578.
6. Long XD, Ma Y, Wei YP, Deng ZL. The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatol Res 2006;36:48-55.
7. Long XD, Ma Y, Zhou YF, Yao JG, Ban FZ, Huang YZ, et al. XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk. BMC Cancer 2009;9:400.
8. Araujo SJ, Wood RD. Protein complexes in nucleotide excision repair. Mutat Res 1999;435:23-33.
9. Batty DP, Wood RD. Damage recognition in nucleotide excision repair of DNA. Gene 2000;241:193-204.
10. Sugasawa K. XPC: its product and biological roles. Adv Exp Med Biol 2008;637:47-56.
11. Qiu L, Wang Z, Shi X, Wang Z. Associations between XPC polymorphisms and risk of cancers: a meta-analysis. Eur J Cancer 2008;44: 2241-2253.
12. Zhang D, Chen C, Fu X, Gu S, Mao Y, Xie Y, et al. A meta-analysis of DNA repair gene XPC polymorphisms and cancer risk. J Hum Genet 2008;53:18-33.
13. Liang J, Gu A, Xia Y, Wu B, Lu N, Wang W, et al. XPC gene polymorphisms and risk of idiopathic azoospermia or oligozoospermia in a Chinese population. Int J Androl 2009;32:235-241.
14. Caronia D, Patino-Garcia A, Milne RL, Zalacain-Diez M, Pita G, Alonso MR, et al. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients. Pharmacogenomics J 2009;9:347-353.
15. De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, Claes K, et al. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat Res 2007;631: 101-110.
16. Dong Z, Guo W, Zhou R, Wan L, Li Y, Wang N, et al. Polymorphisms of the DNA repair gene XPA and XPC and its correlation with gastric cardiac adenocarcinoma in a high incidence population in north China. J Clin Gastroenterol 2008;42:910-915.
17. Francisco G, Menezes PR, Eluf-Neto J, Chammas R. XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis. Eur J Hum Genet 2008;16:724-734.
18. Hansen RD, Sorensen M, Tjonneland A, Overvad K, Wallin H, Raaschou-Nielsen O, et al. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer. Mutat Res 2007; 619:68-80.
19. Mechanic LE, Millikan RC, Player J, de Cotret AR, Winkel S, Worley K, et al. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis 2006;27:1377-1385.
20. Shore RE, Zeleniuch-Jacquotte A, Currie D, Mohrenweiser H, Afanasyeva Y, Koenig KL, et al. Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk. Int J Cancer 2008;122:2101-2105.
21. Takebayashi Y, Nakayama K, Kanzaki A, Miyashita H, Ogura O, Mori S, et al. Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors. Cancer Lett 2001;174: 115-125.
22. Zhang L, Zhang Z, Yan W. Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin Chim Acta 2005;359: 150-155.
23. Zhou RM, Li Y, Wang N, Zhang XJ, Dong XJ, Guo W. Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma [in Chinese]. Ai Zheng 2006;25:1113-1119.
24. Brennan P. Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis 2002;23: 381-387.
25. Long XD, Ma Y, Deng ZL. GSTM1 and XRCC3 polymorphisms: effects on levels of aflatoxin B1-DNA adducts. Chin J Cancer Res 2009;21:177-184.
26. Friedrichs K, Gluba S, Eidtmann H, Jonat W. Overexpression of p53 and prognosis in breast cancer. Cancer 1993;72:3641-3647.
27. Long XD, Ma Y, Huang HD, Yao JG, Qu DY, Lu YL. Polymorphism of XRCC1 and the frequency of mutation in codon 249 of the p53 gene in hepatocellular carcinoma among Guangxi population, China. Mol Carcinog 2008;47:295-300.
28. Fautrel A, Andrieux L, Musso O, Boudjema K, Guillouzo A, Langouet S. Overexpression of the two nucleotide excision repair genes ERCC1 and XPC in human hepatocellular carcinoma. J Hepatol 2005;43:288-293.
29. Miyashita H, Mori S, Tanda N, Nakayama K, Kanzaki A, Sato A, et al. Loss of heterozygosity of nucleotide excision repair factors in sporadic oral squamous cell carcinoma using microdissected tissue. Oncol Rep 2001;8:1133-1138.
30. Cheo DL, Burns DK, Meira LB, Houle JF, Friedberg EC. Mutational inactivation of the xeroderma pigmentosum group C gene confers predisposition to 2-acetylaminofluorene-induced liver and lung cancer and to spontaneous testicular cancer in Trp53-/- mice. Cancer Res 1999;59: 771-775.
31. Li L, Peterson C, Legerski R. Sequence of the mouse XPC cDNA and genomic structure of the human XPC gene. Nucleic Acids Res 1996; 24:1026-1028.
32. Laczmanska I, Gil J, Karpinski P, Stembalska A, Trusewicz A, Pesz K, et al. Polymorphism in nucleotide excision repair gene XPC correlates with bleomycin-induced chromosomal aberrations. Environ Mol Mutagen 2007;48:666-671.
33. Ryk C, Kumar R, Sanyal S, de Verdier PJ, Hemminki K, Larsson P, et al. Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours. Cancer Lett 2006;241:142-149.
34. Sakano S, Matsumoto H, Yamamoto Y, Kawai Y, Eguchi S, Ohmi C, et al. Association between DNA repair gene polymorphisms and p53 alterations in Japanese patients with muscle-invasive bladder cancer. Pathobiology 2006;73:295-303.
35. Cai XL, Gao YH, Yu ZW, Wu ZQ, Zhou WP, Yang Y, et al. A 1:1 matched case-control study on the interaction between HBV, HCV infection and DNA repair gene XPC Ala499Val, Lys939Gln for primary hepatocellular carcinoma [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2009;30:942-945.